To conduct a comprehensive analysis of the relationship between plasma NfL levels and neuronal injury as well as cognitive impairment in AD, we integrated plasma p‐tau217 as a predictive biomarker and concurrently evaluated the associations of both biomarkers with hippocampal atrophy and cognitive phenotypes. This evidence concerns the gene NEFL and Alzheimer disease.